Questcor - Best Pharma Stocks on 2007
Company: Questcor
Starting stock price: $1.45
Ending stock price: $5.77
Percent Change: 298%
Details: Union City, CA-based Questcor Pharmaceuticals develops and commercializes novel CNS-focused therapeutics. With 70 workers and a market cap of $366 million, the company's stock increased an impressive 298% in 2007. It's marketed products include Doral for insomnia and H.P. Acthar Gel.
More stories about Questcor
Comments
Post new comment
Paid Research Reports
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
- Optimizing Lifecycle Management: Maximizing commercial lifespan through label expansion and combination products
- The CRO Market Outlook: Emerging markets, leading players and future trends
- Pharmaceutical Sales Force Effectiveness Strategies
- Commercial Insight: Influenza Vaccines and Antivirals - The pandemic's long-term impact
